Subscribe in seconds and receive Life Sciences Voice's news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.
You can select the updates using tags or topics and you can add as many websites to your feed as you like.
And the service is entirely free!
Follow Life Sciences Voice: Lifescivoice - News and Insights of Life Sciences Industry
Is this your feed? Claim it!
Market access has become one of the most strategically important functions within the pharmaceutical industry. Securing regulatory approval is no longer sufficient to ensure commercial success. Pharmaceutical companies must also demonstrate clini...
Scientific engagement is undergoing one of the most significant transformations in its history.
For decades, scientific exchange in the pharmaceutical industry relied on relatively traditional models. Medical science liaisons (MSLs), medical affairs teams, scientific publications, congresses, advisory boards, and educational programs served as ...
cAMPfield Therapeutics is preparing to advance prifemilast, an oral phosphodiesterase type 4 (PDE4) inhibitor, into mid-stage clinical testing for inflammatory bowel disease (IBD), with plans to launch global studies in both ulcerative colitis and Crohn’s disease.
The San Diego-based biotechnology company will begin a global Phase 2b trial in patients with moderate-to-...
Definium Therapeutics has released topline phase 3 results for its investigational LSD-based depression treatment, delivering data that is likely to further increase interest in psychedelic medicine.
The company’s LSD formulation, DT120 ODT, successfully met both the ...
Merck has reported positive results from the ATLAS-UC induction-only study evaluating tulisokibart in patients with moderately to severely active ulcerative colitis (UC).
According to the company, tulisokibart met the study’s primary endpoint by demonstrating a ...